These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 14510982)

  • 21. A phase II multicenter clinical trial of systemic bexarotene in psoriasis.
    Smit JV; Franssen ME; de Jong EM; Lambert J; Roseeuw DI; De Weert J; Yocum RC; Stevens VJ; van De Kerkhof PC
    J Am Acad Dermatol; 2004 Aug; 51(2):249-56. PubMed ID: 15280844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II clinical trial of bexarotene gel 1% in psoriasis.
    Breneman D; Sheth P; Berger V; Naini V; Stevens V
    J Drugs Dermatol; 2007 May; 6(5):501-6. PubMed ID: 17679184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation.
    Bovenschen HJ; Seyger MM; Van de Kerkhof PC
    Br J Dermatol; 2005 Jul; 153(1):72-8. PubMed ID: 16029329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical treatment of mild to moderate plaque psoriasis with 0.3% tacrolimus gel and 0.5% tacrolimus cream: the effect on SUM score, epidermal proliferation, keratinization, T-cell subsets and HLA-DR expression.
    Vissers WH; van Vlijmen I; van Erp PE; de Jong EM; van de Kerkhof PC
    Br J Dermatol; 2008 Apr; 158(4):705-12. PubMed ID: 18284400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulsed dye laser versus treatment with calcipotriol/betamethasone dipropionate for localized refractory plaque psoriasis: effects on T-cell infiltration, epidermal proliferation and keratinization.
    Bovenschen HJ; Erceg A; Van Vlijmen-Willems I; Van De Kerkhof PC; Seyger MM
    J Dermatolog Treat; 2007; 18(1):32-9. PubMed ID: 17365265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Keratins (K16 and K17) as markers of keratinocyte hyperproliferation in psoriasis in vivo and in vitro.
    Leigh IM; Navsaria H; Purkis PE; McKay IA; Bowden PE; Riddle PN
    Br J Dermatol; 1995 Oct; 133(4):501-11. PubMed ID: 7577575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flow cytometric analysis of epidermal subpopulations from normal and psoriatic skin using monoclonal antibodies against intermediate filaments.
    van Erp PE; Rijzewijk JJ; Boezeman JB; Leenders J; de Mare S; Schalkwijk J; van de Kerkhof PC; Ramaekers FC; Bauer FW
    Am J Pathol; 1989 Nov; 135(5):865-70. PubMed ID: 2479273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clobetasol under hydrocolloid occlusion in psoriasis results in a complete block of proliferation and in a rebound of lesions following discontinuation.
    Mommers JM; van Erp PE; van De Kerkhof PC
    Dermatology; 1999; 199(4):323-7. PubMed ID: 10640842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Response of the clinically uninvolved skin of psoriatic patients to repeated tape stripping during cyclosporin A treatment.
    Gerritsen MJ; Rulo HF; Arnold WP; Van de Kerkhof PC
    Br J Dermatol; 1994 Feb; 130(2):181-8. PubMed ID: 7510122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calcipotriol inhibits the proliferation of hyperproliferative CD29 positive keratinocytes in psoriatic epidermis in the absence of an effect on the function and number of antigen-presenting cells.
    Jensen AM; Lladó MB; Skov L; Hansen ER; Larsen JK; Baadsgaard O
    Br J Dermatol; 1998 Dec; 139(6):984-91. PubMed ID: 9990360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of oral liarozole on epidermal proliferation and differentiation in severe plaque psoriasis are comparable with those of acitretin.
    Kuijpers AL; Van Pelt JP; Bergers M; Boegheim PJ; Den Bakker JE; Siegenthaler G; Van de Kerkhof PC; Schalkwijk J
    Br J Dermatol; 1998 Sep; 139(3):380-9. PubMed ID: 9988537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Memory effector (CD45RO+) and cytotoxic (CD8+) T cells appear early in the margin zone of spreading psoriatic lesions in contrast to cells expressing natural killer receptors, which appear late.
    Vissers WH; Arndtz CH; Muys L; Van Erp PE; de Jong EM; van de Kerkhof PC
    Br J Dermatol; 2004 May; 150(5):852-9. PubMed ID: 15149496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of tacalcitol on cell cycle kinetics of human keratinocytes following standardized injury.
    Mommers JM; ter Meulen AC; van Erp PE; van de Kerkhof PC
    Skin Pharmacol Appl Skin Physiol; 1999; 12(4):174-81. PubMed ID: 10420137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biomolecular index of therapeutic efficacy in psoriasis treated with anti-TNF-α agents.
    Bianchi L; Costanza G; Campione E; Ruzzetti M; Di Stefani A; Diluvio L; Giardina E; Cascella R; Cordiali-Fei P; Bonifati C; Chiricozzi A; Novelli G; Ensoli F; Orlandi A
    G Ital Dermatol Venereol; 2018 Jun; 153(3):316-325. PubMed ID: 27627098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delayed onset of epidermal differentiation in psoriasis.
    Bernerd F; Magnaldo T; Darmon M
    J Invest Dermatol; 1992 Jun; 98(6):902-10. PubMed ID: 1375620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A placebo-controlled randomized study on the clinical effectiveness, immunohistochemical changes and protoporphyrin IX accumulation in fractionated 5-aminolaevulinic acid-photodynamic therapy in patients with psoriasis.
    Smits T; Kleinpenning MM; van Erp PE; van de Kerkhof PC; Gerritsen MJ
    Br J Dermatol; 2006 Aug; 155(2):429-36. PubMed ID: 16882185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Normal psoriatic epidermis expression of hyperproliferation-associated keratins.
    Thewes M; Stadler R; Korge B; Mischke D
    Arch Dermatol Res; 1991; 283(7):465-71. PubMed ID: 1724897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of a topical corticosteroid on short-contact high-dose dithranol therapy.
    Swinkels OQ; Prins M; Tosserams EF; Gerritsen MJ; Van Der Valk PG; Van De Kerkhof PC
    Br J Dermatol; 2001 Jul; 145(1):63-9. PubMed ID: 11453908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of the combination of calcipotriol and betamethasone dipropionate versus both monotherapies on epidermal proliferation, keratinization and T-cell subsets in chronic plaque psoriasis.
    Vissers WH; Berends M; Muys L; van Erp PE; de Jong EM; van de Kerkhof PC
    Exp Dermatol; 2004 Feb; 13(2):106-12. PubMed ID: 15009104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of calcipotriol on epidermal cell populations in alefacept-treated psoriatic lesions.
    van Duijnhoven MW; Körver JE; Vissers WH; van Vlijmen-Willems IM; Pasch MC; van Erp PE; Van de Kerkhof PC
    J Eur Acad Dermatol Venereol; 2006 Jan; 20(1):27-33. PubMed ID: 16405604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.